Growth Metrics

Insulet (PODD) EBT Margin Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -419.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 110.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -300.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -287.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 233.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 772.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -464.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 584.00
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 636.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 636.00
Dec 31, 2025 -76.00
Sep 30, 2025 214.00
Jun 30, 2025 -609.00
Mar 31, 2025 -396.00
Dec 31, 2024 -252.00
Sep 30, 2024 283.00
Jun 30, 2024 327.00
Mar 31, 2024 556.00
Dec 31, 2023 1,513.00
Sep 30, 2023 1,408.00
Jun 30, 2023 1,925.00
Mar 31, 2023 -499.00
Dec 31, 2022 -418.00
Sep 30, 2022 -719.00
Jun 30, 2022 -113.00
Mar 31, 2022 1,174.00
Dec 31, 2021 1,773.00
Sep 30, 2021 -21.00
Jun 30, 2021 -1,862.00
Mar 31, 2021 143.00
Dec 31, 2020 -1,076.00
Sep 30, 2020 515.00
Jun 30, 2020 662.00
Mar 31, 2020 -426.00
Dec 31, 2019 -334.00
Sep 30, 2019 -65.00
Jun 30, 2019 210.00
Mar 31, 2019 799.00
Dec 31, 2018 1,191.00
Sep 30, 2018 296.00
Jun 30, 2018 595.00
Mar 31, 2018 467.00
Dec 31, 2017 332.00
Sep 30, 2017 138.00
Jun 30, 2017 -208.00
Mar 31, 2017 337.00
Dec 31, 2016 1,018.00
Sep 30, 2016 2,202.00
Jun 30, 2016 2,358.00
Mar 31, 2016 855.00
Dec 31, 2015 -1,619.00
Sep 30, 2015 -1,070.00
Jun 30, 2015 1,186.00
Mar 31, 2015 -1,285.00
Dec 31, 2014 123.00
Sep 30, 2014 2,040.00
Jun 30, 2014 -2,304.00
Mar 31, 2014 958.00
Dec 31, 2013 1,364.00
Sep 30, 2013 -1,221.00
Jun 30, 2013 1,092.00
Mar 31, 2013 1,249.00
Dec 31, 2012 1,261.00
Sep 30, 2012 778.00
Jun 30, 2012 3,207.00
Mar 31, 2012 400.00
Dec 31, 2011 4,500.00
Sep 30, 2011 1,712.00
Jun 30, 2011 -52.00